Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 7/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | ALB | P02768 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3966986 | 1.00 | CYP3A4 (0.42) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL841552 | 0.86 | CYP3A4 (0.48) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL14577383 | 0.86 | ERN1 (0.46) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL4650198 | 0.86 | CYP3A4 (0.44) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL4580995 | 0.84 | ERN1 (0.45) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL25322018 | 0.82 | ALDH1A1 (0.46) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL1678780 | 0.82 | ERN1 (0.48) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL1678698 | 0.82 | ALDH1A1 (0.41) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL16346300 | 0.82 | ERN1 (0.50) | CYP3A4MAPTALDH1A1PADI4ERN1 | |
| SCHEMBL29955992 | 0.82 | ALDH1A1 (0.41) | CYP3A4MAPTALDH1A1PADI4ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120117968-A | Process for preparing hydroxy-ortho-hydroxymethyl substituted methylene bridged substituted phenols and polyphenols containing multiple phenol units | 天津久日半导体材料有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-113950476-B | Substituted 4- [5- (benzofuran-2-yl) -1,2, 4-oxadiazol-3-yl ] benzoic acid compounds for the treatment of neuropathic pain | 伦敦皇家学院 | 2024-08-16 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11401265-B2 | Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonists | KING'S COLLEGE LONDON | 2022-08-02 | — | — | US | disclosed |
| CN-109415356-B | Crystalline forms of 4- (5- (4, 7-dimethylbenzofuran-2-yl) -1,2, 4-oxadiazol-3-yl) benzoic acid and methods for their preparation | 伦敦皇家学院 | 2022-03-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11401265-B2 | Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonists | RARB, RARA, RXRB | CYP3A4 2756/4885MAPT 2234/4885ALDH1A1 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.